She graduated in Molecular Biology and Genetics in 2016 at University of Pavia and she completed her Ph.D programme in Molecular and Experimental Medicine in April 2020 at Humanitas University, moving her study in Gastrointestinal immunopathology.

Additionally, Dr. Rubbino is also part of the Biostatistics core at Humanitas University (headed by Prof. Stefanos Bonovas) since she is completing the 2nd level University Master in Biostatistics and Epidemiology at University of Pavia.

On a positive note, she has been exposed to cutting-edge international research as graduand student in the lab of Proteomics and Metabolomics headed by Peter van Veelen (LUMC, Leiden, NL), as a visiting PhD student in the laboratories led by Martin Giera (LUMC, Leiden, NL) working on SCFAs and lipid metabolites, and Hugo de Jonge (Erasmus MC, Rotterdam, NL) learning isolation and culture of human intestinal organoids.

Since 2020, she is working on the study of biomarkers for the innovative clinical management of gastrointestinal cancers (specifically colorectal cancer and pancreatic one).

She just won a two years AIRC fellowship (Associazione Italiana per la Ricerca sul Cancro; Project code: 25484) based on how dietary fatty acids can foster carcinoma-associated CD fistula by activating G-protein coupled receptors”.